Analyst Ratings For GMED – Globus Medical (NYSE:GMED)
Today, GMED – Globus Medical (NYSE:GMED) stock received an upgrade by Needham & Company LLC from Hold to Buy with a price target of $57.00.
Some recent analyst ratings include
- 4/4/2018-Needham & Company LLC Upgrade from a “Hold ” rating to a ” Buy” rating.
- 3/28/2018-Leerink Swann Reiterated Rating of Outperform .
- 3/12/2018-Canaccord Genuity Reiterated Rating of Buy.
- 1/10/2018-Barclays Reiterated Rating of Sell.
Recent Insider Trading Activity For GMED – Globus Medical (NYSE:GMED)
GMED – Globus Medical (NYSE:GMED) has insider ownership of 28.21% and institutional ownership of 65.92%.
- On 3/28/2018 Eric Schwartz, VP, sold 24,000 with an average share price of $50.00 per share and the total transaction amounting to $1,200,000.00.
- On 12/15/2017 Steven Payne, CAO, sold 3,076 with an average share price of $39.30 per share and the total transaction amounting to $120,886.80.
- On 12/13/2017 Anthony L Williams, President, sold 15,000 with an average share price of $38.30 per share and the total transaction amounting to $574,500.00.
- On 12/4/2017 David D Davidar, Director, sold 55,383 with an average share price of $40.66 per share and the total transaction amounting to $2,251,872.78.
- On 11/9/2017 A Brett Murphy, Insider, sold 51,449 with an average share price of $35.00 per share and the total transaction amounting to $1,800,715.00.
- On 9/6/2017 A Brett Murphy, Insider, sold 15,000 with an average share price of $29.99 per share and the total transaction amounting to $449,850.00.
- On 6/5/2017 Anthony L Williams, President, sold 16,153 with an average share price of $31.94 per share and the total transaction amounting to $515,926.82.
Recent Trading Activity for GMED – Globus Medical (NYSE:GMED)
Shares of GMED – Globus Medical closed the previous trading session at with 49.31999969482422 shares trading hands.